+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Anal Fistula Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767476
  • Report
  • 48 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Cellerix
  • Cytori Therapeutics Inc
  • Novartis AG
  • S.A.
  • MORE
The global clinical trial report- “2019 Anal Fistula Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Anal Fistula. It presents in-depth analysis of Anal Fistula clinical trials across markets and companies. The research work is for providing complete understanding into trends in Anal Fistula.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Anal Fistula clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Anal Fistula

The research work is prepared through extensive and continuous research on Anal Fistula trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Anal Fistula patients are identified
  • The report includes panorama of Anal Fistula clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Anal Fistula clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Cellerix
  • Cytori Therapeutics Inc
  • Novartis AG
  • S.A.
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Anal Fistula Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Anal Fistula Clinical Trials by Region
2.2.2 Average Enrollment of Anal Fistula Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Anal Fistula Treatment, 2019

3. Region wise Anal Fistula Clinical Trials
3.1 Asia Pacific Anal Fistula Clinical Trials by Country
3.2 Europe Anal Fistula Clinical Trials by Country
3.3 North America Anal Fistula Clinical Trials by Country
3.4 Middle East and Africa Anal Fistula Clinical Trials by Country
3.5 South and Central America Anal Fistula Clinical Trials by Country

4. Anal Fistula Clinical Trial Trends
4.1 Start Year wise Anal Fistula Clinical Trials
4.2 Phase wise Anal Fistula Clinical Trials
4.3 Trial Status wise Anal Fistula Clinical Trials
4.4 Trial Type wise Anal Fistula Clinical Trials

5. Anal Fistula Average Enrollment Trends
5.1 Average Enrollment in Anal Fistula Trials by Year
5.2 Average Enrollment in Anal Fistula Trials by Phase
5.3 Average Enrollment in Anal Fistula Trials by Status
5.4 Average Enrollment in Anal Fistula Trials by Type of Trial

6. Companies Participating in Anal Fistula Clinical Trials
6.1 Anal Fistula Trials by Sponsor Type
6.2 Anal Fistula Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Anal Fistula Trials- Phase 1
7.2 Anal Fistula Trials- Phase 2
7.3 Anal Fistula Trials- Phase 3
7.4 Anal Fistula Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Anal Fistula Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Anal Fistula Clinical Trials and Enrolment
Figure 5: Europe - Country wise Anal Fistula Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Anal Fistula Clinical Trials and Enrolment
Figure 7: North America - Country wise Anal Fistula Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Anal Fistula Clinical Trials and Enrolment
Figure 9: Anal Fistula Clinical Trials by Phase
Figure 10: Anal Fistula Clinical Trials by Trial Status
Figure 11: Anal Fistula Clinical Trials by Type
Figure 12: Anal Fistula Clinical Trials by Sponsor Type
Figure 13: Anal Fistula Clinical Trials by Leading Sponsors
Figure 14: Anal Fistula Average Enrollment by Phase
Figure 15: Anal Fistula Average Enrollment by Trial Status
Figure 16: Anal Fistula Average Enrollment by Type
Figure 17: Anal Fistula- Average Enrolment by Type of Sponsors
Figure 18: Anal Fistula- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Anal Fistula Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Anal Fistula Clinical Trials and Enrolment
Table 5: Europe - Country wise Anal Fistula Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Anal Fistula Clinical Trials and Enrolment
Table 7: North America - Country wise Anal Fistula Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Anal Fistula Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Anal Fistula Average Enrollment by Phase
Table 15: Anal Fistula Average Enrollment by Trial Status
Table 16: Anal Fistula Average Enrollment by Type
Table 17: Anal Fistula- Average Enrolment by Type of Sponsors
Table 18: Anal Fistula- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Cellerix
  • S.A.
  • Cytori Therapeutics Inc
  • Novartis AG
  • Takeda Pharmaceutical Co Ltd
  • Zimmer Biomet Holdings Inc
Note: Product cover images may vary from those shown
Adroll
adroll